We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$475B
AUM Growth
+$21.4B
Cap. Flow
-$8.62B
Cap. Flow %
-1.82%
Top 10 Hldgs %
17.9%
Holding
5,783
New
811
Increased
2,514
Reduced
1,655
Closed
342

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 12.2%
3 Healthcare 9.44%
4 Consumer Discretionary 8.6%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMPL icon
5026
Simply Good Foods
SMPL
$982M
$14K ﹤0.01%
+956
New +$12K
VXRT
5027
DELISTED
Vaxart
VXRT
$14K ﹤0.01%
+2,170
New +$15.2K
WOOD icon
5028
iShares Global Timber & Forestry ETF
WOOD
$274M
$14K ﹤0.01%
200
RAS
5029
DELISTED
RAIT Financial Trust
RAS
$14K ﹤0.01%
+38,939
New +$17.6K
SDR
5030
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$14K ﹤0.01%
16,480
+7,380
+81% +$8.79K
AST
5031
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$14K ﹤0.01%
+6,381
New +$16.1K
WMLP
5032
DELISTED
Westmoreland Resrc Partners, L.P
WMLP
$14K ﹤0.01%
4,940
-4,558
-48% -$13.4K
ARLZ
5033
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$14K ﹤0.01%
9,353
-1,234
-12% -$2.02K
FLGT icon
5034
Fulgent Genetics
FLGT
$527M
$13K ﹤0.01%
2,943
-889
-23% -$3.4K
GEG icon
5035
Great Elm Group
GEG
$69.3M
$13K ﹤0.01%
+3,313
New +$12.8K
GLP icon
5036
Global Partners
GLP
$1.7B
$13K ﹤0.01%
763
-9,673
-93% -$168K
HIND
5037
Vyome Holdings
HIND
$15.2M
0
CAJ
5038
DELISTED
Canon, Inc.
CAJ
$13K ﹤0.01%
355
-87
-20% -$3.25K
NVTR
5039
DELISTED
Nuvectra Corporation Common Stock
NVTR
$13K ﹤0.01%
1,674
+1,600
+2,162% +$16.8K
EHIC
5040
DELISTED
eHi Car Services Limited
EHIC
$13K ﹤0.01%
1,122
+684
+156% +$7.64K
GZT
5041
DELISTED
Gazit-globe Ltd
GZT
$13K ﹤0.01%
1,186
-2,562
-68% -$25.3K
KYO
5042
DELISTED
Kyocera Adr
KYO
$13K ﹤0.01%
195
+28
+17% +$1.89K
BBH icon
5043
VanEck Biotech ETF
BBH
$422M
$12K ﹤0.01%
95
-34
-26% -$4.34K
CIX icon
5044
Comp X International
CIX
$371M
$12K ﹤0.01%
866
+500
+137% +$7.01K
PZT icon
5045
Invesco New York AMT-Free Municipal Bond ETF
PZT
$140M
$12K ﹤0.01%
500
+50
+11% +$1.23K
RNGR icon
5046
Ranger Energy Services
RNGR
$377M
$12K ﹤0.01%
+1,279
New +$14.2K
SDOG icon
5047
ALPS Sector Dividend Dogs ETF
SDOG
$1.43B
$12K ﹤0.01%
+253
New +$11.4K
SIFY
5048
Sify Technologies
SIFY
$1.14B
$12K ﹤0.01%
1,165
ONCT
5049
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$12K ﹤0.01%
7
-22
-76% -$31.9K
MCEP
5050
DELISTED
Mid-Con Energy Partners, LP
MCEP
$12K ﹤0.01%
522
-22
-4% -$478

Similar funds

JP Morgan Chase's Q4 2017 Portfolio in Review

As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
  • JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
  • JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
  • JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
  • JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
  • JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.